Real-world survival, cognitive, and quality of life outcomes of methotrexate/ifosfamide plus whole brain radiotherapy for newly diagnosed primary central nervous system lymphoma.

Luangmaneerote W, Rattanapong N, Chokesuwattanaskul A, Raiyawa T, Chajuwan T, Jongdee P, Rojnuckarin P, Chanswangphuwana C

Open source

DOI: 10.1177/20406207251400429
Published: 2025
Container: Therapeutic advances in hematology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/20406207251400429,
  title = {Real-world survival, cognitive, and quality of life outcomes of methotrexate/ifosfamide plus whole brain radiotherapy for newly diagnosed primary central nervous system lymphoma.},
  author = {Luangmaneerote W and Rattanapong N and Chokesuwattanaskul A and Raiyawa T and Chajuwan T and Jongdee P and Rojnuckarin P and Chanswangphuwana C},
  year = {2025},
  journal = {Therapeutic advances in hematology},
  doi = {10.1177/20406207251400429},
  url = {https://doi.org/10.1177/20406207251400429}
}

RIS

TY  - JOUR
TI  - Real-world survival, cognitive, and quality of life outcomes of methotrexate/ifosfamide plus whole brain radiotherapy for newly diagnosed primary central nervous system lymphoma.
AU  - Luangmaneerote W
AU  - Rattanapong N
AU  - Chokesuwattanaskul A
AU  - Raiyawa T
AU  - Chajuwan T
AU  - Jongdee P
AU  - Rojnuckarin P
AU  - Chanswangphuwana C
PY  - 2025
JO  - Therapeutic advances in hematology
DO  - 10.1177/20406207251400429
UR  - https://doi.org/10.1177/20406207251400429
ER  -

APA

W, L., N, R., A, C., T, R., T, C., P, J., P, R., & C, C. (2025). Real-world survival, cognitive, and quality of life outcomes of methotrexate/ifosfamide plus whole brain radiotherapy for newly diagnosed primary central nervous system lymphoma.. Therapeutic advances in hematology. https://doi.org/10.1177/20406207251400429

Source records

pubmed · retrieved 2026-09-27T14:39:33.248Z